These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 3934440

  • 1. Action of malotilate on reduced serum cholesterol level in rats with carbon tetrachloride-induced liver damage.
    Wakasugi J, Tawara K, Katami K, Ikeda T, Tomikawa M.
    Jpn J Pharmacol; 1985 Aug; 38(4):391-401. PubMed ID: 3934440
    [Abstract] [Full Text] [Related]

  • 2. [Effect of malotilate (diisopropyl 1, 3-dithiol-2-ylidenemalonate) on chronic liver injury caused by carbon tetrachloride].
    Katoh M, Sugimoto T.
    Nihon Yakurigaku Zasshi; 1982 Jul; 80(1):83-91. PubMed ID: 7173736
    [Abstract] [Full Text] [Related]

  • 3. Protective effect of malotilate (diisopropyl 1,3-dithiol-2-ylidenemalonate) on carbon tetrachloride-induced liver injury in mice and rats.
    Nokata M, Katoh M, Sugimoto T.
    J Toxicol Sci; 1985 Nov; 10(4):279-88. PubMed ID: 3831365
    [Abstract] [Full Text] [Related]

  • 4. Effect of malotilate on chronic liver injury induced by carbon tetrachloride in the rat.
    Dumont JM, Maignan MF, Janin B, Herbage D, Perrissoud D.
    J Hepatol; 1986 Nov; 3(2):260-8. PubMed ID: 3794306
    [Abstract] [Full Text] [Related]

  • 5. Malotilate completely inhibits CCl4-induced liver cirrhosis in rats: biochemical and morphological analysis.
    Suzuki T.
    Fukushima J Med Sci; 1992 Jun; 38(1):19-33. PubMed ID: 1292970
    [Abstract] [Full Text] [Related]

  • 6. Anti-fibrotic effect of malotilate on liver fibrosis induced by carbon tetrachloride in rats.
    Igarashi S, Hatahara T, Nagai Y, Hori H, Sakakibara K, Katoh M, Sakai A, Sugimoto T.
    Jpn J Exp Med; 1986 Oct; 56(5):235-45. PubMed ID: 3027433
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hypolipidemic activity and toxicity studies of a styrl-hexahydroindolinol, 34-250.
    Bagdon RE, Engstrom RG, Kelly LA, Hartman HA, Robison RL, Visscher GE.
    Toxicol Appl Pharmacol; 1983 Jun 15; 69(1):12-28. PubMed ID: 6857683
    [Abstract] [Full Text] [Related]

  • 14. Hypocholesterolemic activity of a novel inhibitor of cholesterol absorption, SCH 48461.
    Salisbury BG, Davis HR, Burrier RE, Burnett DA, Bowkow G, Caplen MA, Clemmons AL, Compton DS, Hoos LM, McGregor DG.
    Atherosclerosis; 1995 May 15; 115(1):45-63. PubMed ID: 7669087
    [Abstract] [Full Text] [Related]

  • 15. [Protective effect of malotilate (diisopropyl 1,3-dithiol-2-ylidenemalonate) on chemical-induced hepatotoxicity].
    Nokata M, Katoh M, Inishi S, Sugimoto T.
    J Toxicol Sci; 1986 Aug 15; 11(3):225-36. PubMed ID: 3795300
    [Abstract] [Full Text] [Related]

  • 16. Hepatoprotection by malotilate against carbon tetrachloride-alcohol-induced liver fibrosis.
    Siegers CP, Pauli V, Korb G, Younes M.
    Agents Actions; 1986 Aug 15; 18(5-6):600-3. PubMed ID: 3766314
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.